Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab
Shoko Miyamoto, Yasutomo Imai, Masaru Natsuaki, et al.
Acta Dermato Venereologica (2022) Vol. 102, pp. adv00731-adv00731
Open Access | Times Cited: 12

Showing 12 citing articles:

The value of biomarkers in the therapy of CRSwNP with biologicals—a long-term follow-up of dupilumab therapy
Sven Ole Sarnoch, Amra Pepić, Lisa Schmitz, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 9, pp. 4789-4805
Open Access | Times Cited: 4
Interleukin-4 and Atopic Dermatitis: Why Does it Matter? A Narrative Review
Tiago Torres, Pedro Mendes‐Bastos, Maria João Cruz, et al.
Dermatology and Therapy (2025)
Open Access
What Does Long-Term Control in Atopic Dermatitis Look Like?
Shanthi Narla, Zelma C. Chiesa Fuxench, Katrina Abuabara, et al.
Dermatitis (2025)
Closed Access
Atopic dermatitis and IgE-mediated food allergy
H. Mark Kenney, Jennifer Battaglia, Katherine Herman, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 3, pp. 262-277
Closed Access | Times Cited: 3
Atopic dermatitis treated safely with dupilumab during pregnancy and lactation: A case series of four patients
Narang Hong, So Yun Park, Hyung Don Kook, et al.
Australasian Journal of Dermatology (2024) Vol. 65, Iss. 4
Closed Access | Times Cited: 2
Possibility of maintaining remission with topical therapy alone after withdrawal of dupilumab in Japanese patients with atopic dermatitis and their characteristics in the real world
Ayu Watanabe, Masahiro Kamata, Yoshiki Okada, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 9
Closed Access | Times Cited: 2
Long-term disease control in atopic dermatitis using biologics
Jacob P. Thyssen, Peter Schmid‐Grendelmeier
The Lancet (2022) Vol. 401, Iss. 10372, pp. 172-173
Closed Access | Times Cited: 4
Real-world efficacy of dupilumab re-administration after discontinuation in patients with atopic dermatitis
Masako Matsutani, Yasutomo Imai, Shoko Miyamoto, et al.
Journal of Cutaneous Immunology and Allergy (2024) Vol. 7
Open Access
Systemic Biologic Management of Atopic Dermatitis
Diem‐Phuong D. Dao, R. Hal Flowers
Advances in experimental medicine and biology (2024), pp. 139-149
Closed Access
Systemic Therapy for Atopic Dermatitis in Children and Adolescents: A United States Expert Consensus
Lawrence F. Eichenfield, Mark Boguniewicz, Christine T. Lauren, et al.
Dermatology (2024), pp. 1-13
Open Access
Addressing Unmet Needs in Atopic Dermatitis: Evaluating Disease-Modifying Capabilities of Current and Emerging Therapies
Sarah G Brooks, Lourdes M Lopez, Kayla D. Mashoudy, et al.
Dermatitis (2024)
Closed Access
Chronic spontaneous urticaria remission definition and therapy stepping-down. WAO Position Paper.
Jorge Sánchez, Helena Pité, René Maximiliano Gómez, et al.
Journal of Allergy and Clinical Immunology (2024)
Closed Access
Page 1

Scroll to top